CERC will be present at TCT Denver, Colorado, feel free to come visit us at Booth (number to be confirmed) Presentation of results : Late Breaking Trial at TCT 2017 (Colorado Convention Center, Denver, Colorado) Session : Main Arena III, Wednesday, Nov 1. Title: SENIOR: A Randomized Trial of a Bioresorbable Polymer-Based Metallic DES vs a BMS with Short DAPT in Patients With Coronary Artery Disease Older than 75 Years Date: Wednesday, November 1st, 2017 Time: 11:00:00 AM – 11:12:00...
CERC will be present at ICI Tel Aviv, feel free to come visit us at Booth (number to be...
Marie-Claure Morice will be present at ESC Congress Barcelona 2017 will do the following lecture : At 14:00 ESC Andreas Grüntzig Lecture on Interventional CardiologyThe revolution in the treatment of patients with aortic...
CERC will be present at EuroPCR 2017 in Paris (Palais des Congrès), which will take place from 16th to 19th of May 2017. We are delighted to welcome you at booth M6 (Level 2) ! To take an appointment, please contact : Isabelle...
Prof Garot from Massy Hospital has enrolled the first patient in the SCOPE II (Safety and efficacy Comparison Of two TAVI in an Prospective randomized Evaluation II: A randomized controlled non-inferiority trial evaluating early safety and clinical efficacy of the Symetis ACURATE NEo compared to the Medtronic Evolut R bioprosthesis in transfemoral transcatheter aortic valve implantation.)...
Dr Gillian Jessurun from Treant Zorggroep, Scheper Hospital has enrolled the first patient in the investigator initiated MASTER DAPT (MAnagement of patients post bioresorbable polymer STEnt implantation with an abbreviated DAPT regimen) study, effectively launching the ambitious global...